Stuart Lutzker

Insider Reports History

Entity
Individual
Location
18 Campus Boulevard, Suite 100, Newtown Square, PA
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Stuart Lutzker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stuart Lutzker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ArriVent BioPharma, Inc. President of R&D, Director Stock Option (right to buy) 120K Feb 3, 2025 Direct

Insider Reports Filed by Stuart Lutzker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVBP ArriVent BioPharma, Inc. Feb 3, 2025 1 $0 4 Feb 14, 2025 President of R&D, Director
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 President of R&D, Director